Journal of Animal Science and Technology
Korean Society of Animal Sciences and Technology

Complete genome sequence of bacteriocin-producing Ligilactobacillus salivarius B4311 isolated from fecal samples of broiler chicken with anti-listeria activity

Subin Han1,#, Arxel G. Elnar1,#, Chiwoong Lim1, Geun-Bae Kim1,*
1Department of Animal Science and Technology, Chung-Ang University, Anseong 17546, Korea

These authors contributed equally to this work.

*Corresponding author: Geun-Bae Kim, Department of Animal Science and Technology, Chung-Ang University, Anseong 17546, Korea., Tel: +82-31-670-3027, E-mail:

© Copyright 2024 Korean Society of Animal Science and Technology. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Feb 28, 2023; Revised: Apr 10, 2023; Accepted: May 01, 2023

Published Online: Jan 31, 2024


Ligilactobacillus is a genus of Gram-positive lactobacilli commonly found in the intestinal tracts of vertebrates. It has been granted a Qualified Presumption of Safety (QPS) status from the European Food Safety Authority (EFSA). One specific strain, Ligilactobacillus salivarius B4311, was isolated from fecal samples of broiler chickens from a farm associated with Chung-Ang University (Anseong, Korea). This strain was observed to have inhibitory effects against Listeria monocytogenes. In this paper, we present the complete genome sequence of Lig. salivarius B4311. The whole genome of strain B4311 comprises 2,071,255 bp assembled into 3 contigs representing a chromosome, repA-type megaplasmid, and small plasmid. The genome contains 1,963 protein-coding sequences, 22 rRNA genes, and 78 tRNA genes, with a guanine + cytosine (GC) content of 33.1%. The megaplasmid of strain B4311 was found to contain the bacteriocin gene cluster for salivaricin P, a two-peptide bacteriocin belonging to class IIb.

Keywords: Ligilactobacillus salivarius; Probiotics; Bacteriocin; Listeria monocytogenes

Bacteriocin production in lactic acid bacteria (LAB) has been consistently gaining attention owing to its potential as a viable alternative to antibiotics. Bacteriocins are ribosomally-synthesized peptides secreted by the producing strain. These peptides can have either a narrow or broad spectrum of activity, which indirectly determines the niche of the producing strain. The production of bacteriocins is generally viewed as a positive trait as it enables the producing strain to hinder potential competitors in the immediate environment as well as inhibit potentially harmful microorganisms [1]. The proteinaceous nature of bacteriocins renders them suitable for human use as they can be inactivated by digestive proteases. With the rapid development of antimicrobial drug resistance in microorganisms [2], research efforts focused on developing alternative solutions must be prioritized.

Commonly associated with vertebrate hosts, Ligilactobacillus is a genus of lactic acid bacteria composed of members that are homofermentative, non-motile, and urease-positive. Their ability to survive in gastric acid conditions and their Qualified Presumption of Safety (QPS) status from the European Food Safety Authority (EFSA) [3] make them popular choices for probiotics. Furthermore, the production of various antimicrobial salivaricins among strains of Lig. salivarius is well accounted for the development of probiotic strains [4]. In the present study, we report the genome analysis of a bacteriocin-producing Ligilactobacillus salivarius (formerly Lactobacillus salivarius) strain B4311, which was isolated from fecal samples collected from broiler chickens.

Strain B4311 was routinely cultured in de Mann, Rogosa, Sharpe ([MRS] BD Difco, Franklin Lakes, NJ, USA) broth supplemented with 0.05% L-cysteine, and incubated aerobically at 37°C for 24 h. Genomic DNA was extracted using the MagAttract HWM DNA Kit (Qiagen, Hilden, Germany) and quantified using Qubit ds DNA HS assay kit (Invitrogen, Waltham, MA, USA) with the Epoch™ Spectrometer (BioTek, Winooski, VT, USA). The genome was sequenced using the Pacific Biosciences (PacBio, Menlo Park, CA, USA) Sequel II platform. De novo assembly of the sequence reads was performed using the PacBio SMAR Analysis program (ver. 2.3.0). Functional annotation of the genome was performed using PRODIGAL ver. 2.6.2 [5] software and compared against protein databases (SwissProt, KEGG, SEED, EggNOG). Rapid annotation was employed using Subsystem Technology (RAST) with default parameters ( Transfer RNAs (tRNA) and non-coding ribosomal RNAs (rRNA) were identified using tRNAscan-SE ver. 1.3.1 [6] and INFERNAL ver. 1.1.3 [7], respectively.

The complete genome of Lig. salivarius B4311 is 2,071,255 base pair (bp) which is assembled into three contigs: a single chromosome (1,801,655 bp), one megaplasmid (247,930 bp), and a small plasmid (21,670 bp) with a guanine + cytosine (GC) content of 33.1%. In addition, the genome contains 1,963 protein-coding sequences (CDS), 22 rRNA genes, and 78 tRNA genes. The genome features and circular maps of strain B4311 are presented in Table 1 and Fig. 1, respectively. Antimicrobial resistance genes, specifically for tetracycline and glycopeptides, were also detected via Resistance Gene Identifier ([RGI] Among the 1,963 CDS, 1,241 were predicted with biological functions associated with cell cycle (n = 23), cell wall and motility (n = 116), cellular response (n = 69), DNA processing (n = 154), RNA processing (n = 119), protein processing (n = 202), defense mechanism (n = 31), energy production (n = 63), and transport and metabolism (n = 464). Additionally, 61 putative genes were detected with putative functions including stress response, DNA and RNA processing, antibiotic resistance, periplasm signaling, acetylation, amino acid transport, and production of enzymes including various hydrolases, methyltransferases, and transport proteins.

Table 1. Genome features of Ligilactobacillus salivarius B4311
Attribute Value
Chromosome Megaplasmid Plasmid Total
Size (bp) 1,801,655 247,930 21,670 2,071,255
GC content (%) 33.24 32.25 33.68 33.1
No. of contigs 1 1 1 3
Total genes 1,768 273 22 2,063
Protein-coding gene 1,668 273 22 1,963
tRNA 78 - - 78
rRNA 22 - - 22

bp, base pair; GC, guanine + cytosine.

Download Excel Table
Fig. 1. Circular map of Ligilactobacillus salivarius B4311 genome. Circles represent the following characteristics from the outermost circle to the center: (1) contig information, (2) coding sequences on forward strand, (3) coding sequences on reverse strand, (4) transfer RNAs (tRNAs) and ribosomal RNAs (rRNAs), (5) GC skew, and (6) GC ratio. G, guanine; C, cytosine; CDS, coding sequences.
Download Original Figure

In silico analysis of the B4311 genome using BAGEL4 online program ( revealed the presence of a bacteriocin gene cluster for salivaricin P, a family of two-peptide bacteriocins belonging to class IIb. This bacteriocin family was originally discovered from Lig. salivarius DPC6005 [6] and is commonly produced among strains of Lig. salivarius isolated from animals intestines [8]. The salivaricin P gene cluster is located in the repA-type megaplasmid. Although the presence of megaplasmids is considered a typical feature of Lig. salivarius, variations exist among megaplasmid-encoded traits, including contingency metabolism genes (i.e., assimilation of sugars) and the presence or absence of bacteriocin genes, which provides a competitive advantage.

The genetic architecture of the bacteriocin gene cluster (Fig. 2) revealed the presence of two open reading frames (ORFs) encoding the salivaricin P chain A and chain B. The two peptide chains share a homologous sequence. Located downstream of the genes for the bacteriocin peptides are two ORFs encoding a histidine kinase and AbpR, which function as regulator proteins [9]. These are followed by AbpIM which encodes an immunity protein. These five ORFs are flanked by two comC genes, which have been reported as competence-stimulating peptide precursors in streptococci [10]. At the 3’ end of the gene cluster, two export proteins, LanT and HlyD were detected, encoding AbpT and AbpD bacteriocin export accessory proteins, respectively. Several ORFs encoding bacteriocin core peptides (i.e., lactacin F and plantaricins) were also detected. However, the similarity of these genes with the reference was poor, suggesting that the translated peptides might be inactive.

Fig. 2. Predicted bacteriocin gene cluster in Ligilactobacillus salivarius B4311genome showing two ORFs for salivaricin P core peptides. ORF, open reading frame.
Download Original Figure

Production of active bacteriocins was demonstrated by spot-on-lawn assay against Listeria monocytogenes ATCC 19114 and ATCC 19115 strains. The cell-free supernatant of strain B4311 successfully inhibited the growth of Lis. monocytogenes (unpublished data), a common foodborne pathogen associated with raw and unpasteurized milk and the causative agent of listeriosis. The genomic information presented in this study confirms the ability of strain B4311 to elaborate bioactive peptides, which can have valuable applications in the food and animal industries.


The sequence obtained in this Whole Genome Shotgun project has been deposited in DDBJ/ENA/GenBank under the accession number CP117983-CP117985. The BioProject accession number PRJNA932943 is and the Biosample accession number is SAMN33215311.

Competing interests

No potential conflict of interest relevant to this article was reported.

Funding sources

This research was supported by the Chung-Ang University Graduate Research Scholarship (Academic Scholarship for College of Biotechnology and Natural Resources) in 2021.


Not applicable.

Availability of data and material

Upon reasonable request, the datasets of this study can be available from the corresponding author.

Authors’ contributions

Conceptualization: Kim GB.

Data curation: Han S, Elnar AG.

Formal analysis: Elnar AG, Kim GB.

Methodology: Elnar AG, Kim GB.

Software: Elnar AG, Lim C, Kim GB.

Validation: Kim GB.

Investigation: Elnar AG.

Writing - original draft: Han S, Elnar AG.

Writing - review & editing: Han S, Elnar AG, Lim C, Kim GB.

Ethics approval and consent to participate

This article does not require IRB/IACUC approval because there are no human and animal participants.



Dobson A, Cotter PD, Ross RP, Hill C. Bacteriocin production: a probiotic trait?. Appl Environ Microbiol. 2012; 78:1-6


Darbandi A, Asadi A, Mahdizade Ari M, Ohadi E, Talebi M, Halaj Zadeh M, et al. Bacteriocins: properties and potential use as antimicrobials. J Clin Lab Anal. 2022; 36e24093


EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, et al. Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 12: suitability of taxonomic units notified to EFSA until March 2020. EFSA J. 2020; 18e06174


Dec M, Stępień-Pyśniak D, Puchalski A, Hauschild T, Pietras-Ożga D, Ignaciuk S, et al. Biodiversity of Ligilactobacillus salivarius strains from poultry and domestic pigeons. Animals. 2021; 11:972


Hyatt D, Chen GL, LoCascio PF, Land ML, Larimer FW, Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics. 2010; 11:119


Barrett E, Hayes M, O’Connor P, Gardiner G, Fitzgerald GF, Stanton C, et al. Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius. Appl Environ Microbiol. 2007; 73:3719-23


Nawrocki EP, Eddy SR. Infernal 1.1: 100-fold faster RNA homology searches. Bioinformatics. 2013; 29:2933-5


Messaoudi S, Manai M, Kergourlay G, Prévost H, Connil N, Chobert JM, et al. Lactobacillus salivarius: bacteriocin and probiotic activity. Food Microbiol. 2013; 36:296-304


Barbour A, Wescombe P, Smith L. Evolution of lantibiotic salivaricins: new weapons to fight infectious diseases. Trends Microbiol. 2020; 28:578-93


Håvarstein LS, Hakenbeck R, Gaustad P. Natural competence in the genus Streptococcus: evidence that streptococci can change pherotype by interspecies recombinational exchanges. J Bacteriol. 1997; 179:6589-94